@replimune.com
Replimune is pioneering the development of a novel class of tumor-directed oncolytic immunotherapies designed to deliver transformational results for difficult-to-treat cancers.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Replimune is a pioneering brand that is revolutionizing cancer treatment with its innovative class of tumor-directed oncolytic immunotherapies. Their primary goal is to deliver transformative results for patients with difficult-to-treat cancers. Replimune's groundbreaking therapies work in two crucial ways: firstly, they enable the immune system to recognize the tumor as foreign, and secondly, they activate a patient-specific immune response, effectively killing the tumor locally and modifying the tumor microenvironment.
These cutting-edge therapies are designed to be tolerable and are specifically tailored for the treatment of challenging cancers. Replimune is currently conducting multiple clinical trials to evaluate the safety and effectiveness of their investigational therapies, both as standalone treatments and in combination with other immunotherapies. With a strong focus on advancing cancer treatment, Replimune is at the forefront of groundbreaking medical discoveries
Company Type
Public Company
Company Size
201-500
Year Founded
2015
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories